How are Isovue adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Isovue, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Isovue is flagged as the suspect drug causing the adverse event.
What are the most common Isovue adverse events reported to the FDA?
Hypersensitivity | 112 (3.84%) |
Dyspnoea | 111 (3.81%) |
Urticaria | 96 (3.29%) |
Pruritus | 70 (2.4%) |
Anaphylactic Reaction | 64 (2.19%) |
Contrast Media Reaction | 63 (2.16%) |
Anaphylactoid Reaction | 54 (1.85%) |
Vomiting | 54 (1.85%) |
Nausea | 51 (1.75%) |
Anaphylactic Shock | 47 (1.61%) |
Convulsion | 40 (1.37%) |
![]() |
Share/Embed Graph
Export Data
This graph shows the top adverse events submitted to the FDA for Isovue, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Isovue is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Isovue adverse events reported to the FDA?
Allergic Conditions | 295 (10.11%) |
Respiratory | 291 (9.98%) |
Epidermal And Dermal Conditions | 190 (6.51%) |
Neurological | 168 (5.76%) |
Cardiac Arrhythmias | 144 (4.94%) |
Gastrointestinal Signs | 140 (4.8%) |
Cardiac And Vascular Investigations | 120 (4.11%) |
Procedural And Device Related Injur... | 115 (3.94%) |
Angiedema And Urticaria | 102 (3.5%) |
Seizures | 48 (1.65%) |
Musculoskeletal And Connective Tiss... | 41 (1.41%) |
![]() |
Share/Embed Graph
Export Data
This graph shows the top categories of adverse events submitted to the FDA for Isovue, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Isovue is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Isovue, according to those reporting adverse events to the FDA?
Computerised Tomogram | 300 |
Catheterisation Cardiac | 103 |
Computerised Tomogram Abdomen | 73 |
Angiogram | 62 |
Abdominal Pain | 48 |
Spinal Myelogram | 47 |
![]() |
Label | Labeler | Effective |
---|---|---|
Isovue250 | Bracco Diagnostics Inc | 23-JAN-12 |
Isovue-m | Bracco Diagnostics Inc | 23-JAN-12 |
Isovue300 | Bracco Diagnostics Inc | 23-JAN-12 |
Isovue370 | Bracco Diagnostics Inc | 23-JAN-12 |
Isovue200 | Bracco Diagnostics Inc | 23-JAN-12 |
Isovue250 | Bracco Diagnostics Inc | 26-JAN-12 |
Isovue300 | Bracco Diagnostics Inc | 26-JAN-12 |
Isovue370 | Bracco Diagnostics Inc | 26-JAN-12 |
Isovue-m 200 | General Injectables & Vaccines, Inc. | 19-APR-12 |
What Isovue safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Isovue. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Isovue.